Navigation Links
Frost & Sullivan Recognizes Cytomedix for its Pioneering System that Supports the Emerging Regenerative Therapies Market
Date:3/6/2013

s valuable potential, Cytomedix is the worthy recipient of the 2012 Frost & Sullivan New Product Innovation Award in the regenerative therapies market.

Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased ROI it offers customers, which, in turn, increases customer acquisition and overall market penetration potential.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Cytomedix
Cytomedix, Inc. is an autologous regenerative therapies company commercializing innovative platelet technologies for orthopedics and wound care with a pipeline of adult stem cell therapies for tissue repair. The Company markets the AutoloGel™ System, a device for the production of autologous platelet rich plasma ("PRP") gel for use on a variety of exuding wounds and the Angel® Concentrated Platelet Rich Plasma System, a blood processing device and disposable products used for the separation of whole blood and bone marrow into red cells, platelet poor plasma ("PPP") and PRP.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Frost & Sullivan: Government Support Vital to Encourage Venture Capital Investments in the North American Healthcare Industry
2. Product Differentiation to Boost European Human Growth Hormones Market, Says Frost & Sullivan
3. Frost & Sullivan Recognizes KAERs Game-Changing Innovating Aerosol Drug Delivery Methods for High-Dose Respiratory Disease Therapeutics
4. Frost & Sullivan Recognizes GenePOCs Growth Backed by Strong Leadership and Technology Excellence
5. Frost & Sullivan Accolade for Swissrays Exceptional Dedication to its Customers
6. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
7. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
8. Frost & Sullivan Acknowledges that PKCs Biosensors are Expected to Become the New Industry Standard in Pathogen Testing
9. Increasing Surgical Volumes to Boost Use of Tissue Sealants and Topical Haemostats, Says Frost & Sullivan
10. Frost & Sullivan: Digitisation of Australias healthcare system met with widespread apprehension
11. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Conn. , Sept. 19, 2014 UBM ... , a leading online community to help oncologists and ... information available regarding the use of targeted therapies and ... cancer research and treatment.  Every September, ... a way to raise awareness about blood cancers—helping to ...
(Date:9/19/2014)... -- According to market research report, ... & Laboratory), Industry (Food, Pharmaceutical, Biotechnology, Surgical Procedure, ... Geography - Global Trends & Forecast to 2019", ... market on the basis of various types, applications, ... market size of each of these segments in ...
(Date:9/19/2014)... DIEGO , Sept. 19, 2014  Lpath, ... leader in bioactive lipid-targeted therapeutics, announced today that ... 3,605,042 registered shares of common stock and 3,605,042 ... combined purchase price for one registered share of ... one unregistered share of common stock will be ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... NEW YORK, Nov. 10 Reportlinker.com announces that ... in its catalogue. , Infections ... http://www.reportlinker.com/p0161914/Infections-Ear-Infections.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , Life Science Analytics, ... the current drug pipeline. This report provides ...
... JumpStart Inc., the Northeast Ohio venture development ... early-stage businesses, announced a JumpStart Ventures investment commitment ... of NDI Medical, the Highland Hills, OH medical ... handheld disposable nerve stimulator. , (Logo: ...
Cached Medicine Technology:Reportlinker Adds Infections Ear Infections 2Reportlinker Adds Infections Ear Infections 3JumpStart Invests in Checkpoint Surgical 2JumpStart Invests in Checkpoint Surgical 3
(Date:9/19/2014)... made from the wonder material graphene has been used ... developing cancer. , The biosensor has been shown ... bioassay tests currently in use, and was able to ... the possibility of a rapid, point-of-care diagnostic tool for ... September, in IOP Publishing,s journal 2D Materials . ...
(Date:9/19/2014)... September 19, 2014 Follow ... assays used for detection and quantification of the ... sample. Driven by steady expansion in immunodiagnostics and ... global immunoassay systems market has evolved remarkably well ... such as diabetes, cardio-vascular ailments, infectious diseases, allergy ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Recent ... freight trucking industry increased their sales by 7% in ... from the trucking industry can be used as a ... as a whole. This data has been proven to ... forms of freight transportation. Other non-trucking data is largely ...
(Date:9/19/2014)... Follow us on LinkedIn ... and immunosuppressant drugs to prevent rejection, organ transplantation ... diseases related to the heart, kidneys, lungs, pancreas, ... have phenomenally revolutionized the survival rate of terminal ... a pivotal medical intervention for thousands of patients ...
(Date:9/19/2014)... of the QUT Centre for Accident Research & Road ... the Occupational Safety in Transport Conference (OSIT) which is ... , Dr Ross Blackman, a CARRS-Q road safety researcher, ... when reduced speed limits and related traffic controls remained ... as crying wolf. If people are asked to slow ...
Breaking Medicine News(10 mins):Health News:Graphene sensor tracks down cancer biomarkers 2Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 4Health News:LeaseQ Announces Good News For The Truck Leasing Industry As Truck Rentals In The U.S Continues to Gain Traction 2Health News:LeaseQ Announces Good News For The Truck Leasing Industry As Truck Rentals In The U.S Continues to Gain Traction 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Don't cry wolf: Drivers fed up with slowing down at inactive roadwork sites 2
... Health Plans Move Closer to Cutting AmerisourceBergen-Brand,Pharmacies ... WASHINGTON, Feb. 28 AmerisourceBergen (NYSE:,ABC) warehouse ... hundreds of,their fellow Teamsters outside ABC,s annual ... a warning to investors about,ongoing and illegal ...
... Standardized ... Digital RSA Solution, ... IDL), the global leader in digital radiography (DR) for image,quality ... as the DR component for an imaging product suite currently,under ...
... study from the American Cancer Society finds that while breast ... U.S. state, for African American women, death rates are either ... study, published early online in the journal Cancer Causes and ... are decreasing in only 11 of 37 states with sufficient ...
... Dental Experts to Advance ... of CCLAD in Dentistry, LIVINGSTON, N.J., Feb. 28 ... leader in,advanced injection technologies, today reported that earlier this ... (CCLAD) Summit in New Orleans. The Summit welcomed a ...
... to unprotected, masochistic sex as adults , , THURSDAY, Feb. ... consequence of spanking: risky sexual behaviors, or even sexual ... one more harmful side effect to spanking," said Murray ... the findings of four studies at the American Psychological ...
... on March 17, 2008 at 10:00 a.m., FREEHOLD, ... NAHC ) will report financial results,for the fourth ... March,17, 2008 prior to market open., The Company ... March,17, 2008 at 10:00 a.m. Eastern Time (ET). Following ...
Cached Medicine News:Health News:Teamsters Warn of Possible Work Stoppages, Service Disruptions at AmerisourceBergen 2Health News:IDC X-Series DR system selected for use in leading edge RSA clinical trial application 2Health News:IDC X-Series DR system selected for use in leading edge RSA clinical trial application 3Health News:Breast cancer death rates among black women not decreasing across all states 2Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 2Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 3Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 4Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 5Health News:Spanking Raises Chances of Risky, Deviant Sexual Behavior 2Health News:Spanking Raises Chances of Risky, Deviant Sexual Behavior 3Health News:National Atlantic Holdings Corporation to Report Fourth Quarter and Year-End 2007 Earnings on March 17, 2008 2Health News:National Atlantic Holdings Corporation to Report Fourth Quarter and Year-End 2007 Earnings on March 17, 2008 3
Intermittent catheter...
Intermittent catheter...
The SJM Sguin annuloplasty ring, a semi-rigid ring, is constructed of a one-piece solid core of ultra-high-weight polyethylene enclosed in a knitted polyester sewing cuff....
... Welcome to a new dimension ... a liquid tool composed of purified ... surgical capabilities. Perfluoron is ideal for ... vitreoretinopathy, giant retinal tears and trauma. ...
Medicine Products: